Study of GRT-R910 COVID-19 Boost Vaccine in Healthy Volunteers
Clinical trial NCT05148962 · COMPLETED
Trial details
- NCT number
- NCT05148962
- Sponsor
- Gritstone bio, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-16
- Primary completion
- 2023-05-26
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.